New hepatitis C treatments more effective, tolerable: FDA

May 11, 2017

(HealthDay)—Hepatitis C can be cured in about three months, allowing people with the viral disease to live longer, healthier lives, the U.S. Food and Drug Administration (FDA) says.

Drugs used to clear the virus from the body are not only more effective than they once were but also more tolerable for , according to Dr. Jeffrey Murray, an internist at the FDA who specializes in infectious diseases.

Hepatitis is inflammation of the liver that is caused by different viruses. In the United States, hepatitis C is the most common chronic bloodborne infection. Avoiding risky behaviors, such as sharing drug needles, can help prevent the spread of the disease, but there is no vaccine for hepatitis C.

Hepatitis is often a silent disease. Many people are unaware they are infected for years and learn about their infection only after they have developed serious liver disease or failure.

Three-quarters of Americans with C are baby boomers (born between 1945 and 1965). Many became infected before the virus was identified and the blood supply was screened, according to the FDA.

"Hepatitis C is a bit like smoking, the longer you've had it, the higher your risk of developing complications—in this case, , cirrhosis [liver scarring] and end-stage liver disease. It's a progressive that takes years, even decades, before the patient develops cirrhosis or cancer," Murray said in an FDA news release.

"The good news is that when you cure hepatitis C, you also lower its risks, though you don't completely erase the years of damage to your ," he added.

In the past, being diagnosed with hepatitis C meant months of painful drug injections with interferon-based injections.

"Interferon-based injections often make patients feel ill and give them flulike symptoms,

Murray said. The drug also cures only about half of those with hepatitis C, according to the FDA.

Today, patients with the condition have more and better options. "Now, patients can treat their hepatitis C with only pills—drug combinations that are faster and have a higher cure rate," Murray said.

Newer hepatitis C medications have doubled the hepatitis C cure rates. The new treatments can reach between a 90 to 100 percent cure rate within about 12 weeks. Not only has treatment becomes faster, but it's also easier for patients to take an oral medication than receive injections, the FDA said.

The U.S. Centers for Disease Control and Prevention advises Americans born between 1945 and 1965, or have other risk factors such as receiving kidney dialysis or using needles, to get a blood test to screen for hepatitis C.

"When it comes to C, the outlook for the future is better, but the past is catching up with us—especially if you are a baby boomer," Murray said.

Explore further: FDA approves hep C drugs for kids 12 and older

More information: The U.S. Centers for Disease Control and Prevention provides more information on hepatitis C.

Related Stories

FDA approves hep C drugs for kids 12 and older

April 7, 2017
(HealthDay)—The U.S. Food and Drug Administration has approved two drugs to treat hepatitis C infection in children aged 12 and older.

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

Hepatitis B and C may be linked to increased risk of Parkinson's disease

March 29, 2017
The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy ...

Drug for one hepatitis type may activate another: watchdog

December 2, 2016
Drugs against one type of hepatitis may activate another, sometimes with fatal consequences, Europe's medicines watchdog warned on Friday.

Successful treatment for hepatitis C reduces risk of liver cancer later in veterans

April 25, 2016
A new study by researchers at Baylor College of Medicine found that treatment and cure of chronic hepatitis C reduce the risk of hepatocellular carcinoma (HCC), especially if given early, before cirrhosis develops, and while ...

Hepatitis C screening for baby boomers

April 29, 2013
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.